英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
assertio查看 assertio 在百度字典中的解释百度英翻中〔查看〕
assertio查看 assertio 在Google字典中的解释Google英翻中〔查看〕
assertio查看 assertio 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Assertio Holdings
    Intended for residents of the United States only © 2026 Assertio Holdings, Inc All rights reserved
  • Assertio to Be Acquired by Zydus Worldwide DMCC for $23. 50 Per Share in . . .
    Under the terms of the Zydus Transaction, Zydus will promptly commence a tender offer to acquire all outstanding shares of Assertio common stock for $23 50 per share in cash, without interest,
  • Zydus Life acquires US-based Assertio for $166 million cash
    Zydus Lifesciences, based in Ahmedabad, has acquired US-based Assertio Holdings for $166 4 million, enhancing its specialty and oncology presence in the US market This strategic acquisition includes key pharmaceutical assets and aligns with Zydus's long-term growth strategy
  • Zydus to Acquire Assertio in $166 Million Deal
    Following the board’s decision, Assertio will terminate the revised Garda merger agreement that had been announced earlier this month and proceed with the transaction involving Zydus The acquisition represents a substantial premium for Assertio shareholders
  • Assertio Therapeutics to be acquired by Zydus Worldwide
    Assertio will be acquired by Zydus via a $23 50-per-share cash tender offer The merger triggers Fundamental Change rights for convertible noteholders to redeem or convert Looking for the best stocks to buy? Follow the recommendations of top-performing analysts
  • Zydus to acquire Assertio in all-cash tender offer
    Zydus intends to leverage Assertio’s focused commercial infrastructure and oncology relationships to build and expand its specialty oncology presence in the US Under the terms of the merger agreement, Zydus will commence a tender offer to acquire all outstanding shares of Assertio common stock
  • $166. 4M Deal Between Zydus Lifesciences and Assertio Holdings; GMP . . .
    Zydus Lifesciences will acquire Assertio Holdings in a $166 4m deal as the company continues expanding its specialty and biologics portfolio in regulated markets The transaction, expected to close in Q2 2026, highlights the growing pace of pharma consolidation and could increase industry attention on post-merger integration challenges involving GMP compliance, quality systems, and operational
  • Zydus to Acquire US Oncology Pharma Firm Assertio in USD 166 Million . . .
    New Delhi: Zydus Lifesciences has announced that its subsidiary Zydus Worldwide DMCC has entered into a definitive agreement to acquire US-based pharmaceutical company Assertio Holdings Inc in an all-cash deal valued at around USD 166 4 million As part of the transaction, Zydus will acquire all
  • ASRT Stock Price | Assertio Holdings Inc. Stock Quote (U. S. : Nasdaq . . .
    Assertio Holdings, Inc is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers The firm focuses on portfolio of neurology, inflammation, and pain
  • Assertio Therapeutics - Wikipedia
    As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor [7] The company's products include Gralise, Cambia, Lazanda, Zipsor, and DM-1992, which mainly focus on pain, neuropathic pain, and central nervous system diseases





中文字典-英文字典  2005-2009